Granahan Investment Management’s QIAGEN NV QGENF Stock Holding History

Granahan Investment Management’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-535,700	Closed	-$14.7M	–	259
2016 Q3	$14.7M	Hold	535,700	–	–	0.48%	87
2016 Q2	$11.7M	Sell	535,700 -239,300	-31%	-$5.22M	0.43%	91
2016 Q1	$17.3M	Sell	775,000 -276,000	-26%	-$6.17M	0.63%	57
2015 Q4	$29.1M	Hold	1,051,000	–	–	1%	24
2015 Q3	$27.1M	Hold	1,051,000	–	–	0.84%	34
2015 Q2	$26.1M	Hold	1,051,000	–	–	0.74%	45
2015 Q1	$26.5M	Buy	1,051,000 +224,000	+27%	+$5.64M	0.76%	42
2014 Q4	$19.4M	Hold	827,000	–	–	0.57%	69
2014 Q3	$18.8M	Hold	827,000	–	–	0.58%	69
2014 Q2	$20.2M	Hold	827,000	–	–	0.59%	62
2014 Q1	$17.4M	Hold	827,000	–	–	0.47%	82
2013 Q4	$19.7M	Hold	827,000	–	–	0.51%	78
2013 Q3	$17.7M	Sell	827,000 -86,800	-9%	-$1.86M	0.47%	85
2013 Q2	$18.2M	Buy	+913,800	New	+$18.2M	0.52%	74

Other funds holding QGENF

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Granahan Investment Management's QGENF Position: Q4 2016 in Review

Granahan Investment Management sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 535,700 shares — an estimated $14.7M sold.

Granahan Investment Management first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $29.1M in Q4 2015. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

Granahan Investment Management reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
Granahan Investment Management sold 535,700 QIAGEN NV shares in Q4 2016, an estimated $14.7M.
Granahan Investment Management first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
Granahan Investment Management's QIAGEN NV position peaked at $29.1M in Q4 2015.
189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on Granahan Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.